InterVene, Inc. Wins TCT 2019 Shark Tank Innovation Competition
September 29, 2019
InterVene wins the Shark Tank Innovation Competition at the 2019 Transcatheter Cardiovascular Therapeutics (TCT) Conference, a premier educational meeting focusing on interventional cardiovascular medicine.
For a 10 minute company description and status update, refer to the following 2019 TCT Shark Tank competition presentation.
InterVene Raises $15 Million in Series B Funding for First Catheter-Based System to Correct Deep Vein Valve Failure
June 25, 2019
InterVene Inc. has raised $15 million for its BlueLeaf® Endovenous Valve Formation System, the first catheter-based solution for deep vein reflux.
InterVene Raises $5.9 Million in Series A Funding to Correct Deep Vein Valve Insufficiency with Minimally Invasive Catheter Technology
March 23, 2015
InterVene announced the initial closing of $5.9MM in Series A funding for trials of its minimally invasive catheter therapy for deep vein valve insufficiency, creating new valves from the vein wall.